EFOR
Efoora IncOTCGREYHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
—
52W High
$0.00
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
0.00%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Efoora Inc
Efoora Inc. develops rapid diagnostic tests and biosensors for testing and diagnosing diseases including HIV, Hepatitis B and C, malaria, pregnancy, bovine spongiform encephalopathy (BSE), and chronic wasting disease (CWD). The company is headquartered in Buffalo Grove, Illinois.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/25/2026